MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
Safety and Feasibility of the MyokinE100 System in ICU Settings to Mitigate ICU Acquired Weakness
Health Discovery Labs
50 participants
May 5, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if a new medical device that sends electrical signals to the thigh muscles is safe and easy to use for people in the ICU (Intensive Care Unit) who are at risk of losing muscle strength. It will also explore whether this treatment can help slow down muscle weakening. The main questions this study aims to answer are: * Do participants develop medical problems when receiving electrical muscle stimulation in the ICU? * Is electrical muscle stimulation a practical way to help reduce muscle weakness in critically ill patients? Researchers will compare the control group (standard of care) to the intervention group (standard of care plus 60-minute sessions of electrical muscle stimulation daily during the ICU stay) to see if the device is safe and easy to use. Participants will: * Receive either standard of care or standard of care plus electrical muscle stimulation of the thigh muscles * Have their muscle strength checked during the study * Complete a survey three months after ICU discharge to check on their recovery
Eligibility
Inclusion Criteria4
- Admitted to ER or ICU within the previous 48 hours
- APACHE II score ≥ 13
- Meets the criteria for sepsis or severe sepsis
- Baseline Clinical Frailty Scale (CFS) ≤ 4
Exclusion Criteria13
- Anticipated transfer to an ICU not participating in this study
- Expected length of ICU stay < 48 hours
- Myopathies (e.g. congenital)
- Acquired myopathies with CK levels 5-times above the upper limit of normal
- Unable to transfer from bed to chair at baseline
- Moribund
- Comfort care
- New onset deep vein thrombosis within the previous 6-months
- Malignancy in lower limb
- Technical obstacles - fracture, burns, amputation
- Open wound or skin abrasion at the garment application site
- Pregnancy
- Pacemaker and implantable cardioverter-defibrillator
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive electrical muscle stimulation at the level of the quadriceps using the MyokinE100 device, a closed-loop electrical muscle stimulation system. The closed-loop system monitors muscle response to electrical stimulation in real time using a biofeedback sensor and automatically adjusts stimulation intensity to achieve safe and effective muscle contractions.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07362862